Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.06
5% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $300.0M | $1.01B | $1.84B | $467.0M | $561.0M | $822.0M | $901.0M | $1.05B |
| Cost of revenue | $50.0M | $469.0M | $1.39B | $370.0M | $424.0M | $275.0M | $281.0M | $307.9M |
| Gross profit | $250.0M | $546.0M | $449.0M | $97.0M | $137.0M | $547.0M | $620.0M | $737.8M |
| Gross margin | 83.3% | 53.8% | 24.4% | 20.8% | 24.4% | 66.5% | 68.8% | 70.6% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$233.0M | −$68.0M | −$269.0M | −$358.0M | −$328.0M | −$89.0M | −$34.0M | $98.0M |
| EBITDA | −$120.0M | $58.0M | −$243.0M | −$193.0M | −$39.0M | $96.0M | $317.0M | $284.9M |
| Net income | −$437.0M | −$295.0M | −$749.0M | −$825.0M | −$598.0M | −$466.0M | −$230.0M | −$69.0M |
| Net margin | -145.7% | -29.1% | -40.6% | -176.7% | -106.6% | -56.7% | -25.5% | -6.6% |
| EPS (diluted) | -1.09 | -0.73 | -0.47 | -0.42 | -0.29 | -0.23 | -0.11 | -0.03 |
Annual figures · source: Financial Modeling Prep
PACIFIC CENTURY PREM DEV
No one on the platform currently holds PCPDF.
No tracked institution reports a position in PCPDF as of their last filing.
No one on the platform has traded PCPDF yet.
| +0.00% |
| $6M |
| — |
| MSGNFMan Sang International Limited | $0.00 | +0.00% | $970798 | — |
| REACREAC Group, Inc. | $0.00 | +0.00% | $8680 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.0× sales vs its 0.1× historical median P/S.
Fair value ≈ $0.06 · price $0.00 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.